A Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of Escalating Single Doses of ITI-214 in Patients with Systolic Heart Failure
Clinical Trial Grant
Awarded By
Intra-Cellular Therapies, Inc.
Start Date
September 5, 2017
End Date
December 31, 2020
Awarded By
Intra-Cellular Therapies, Inc.
Start Date
September 5, 2017
End Date
December 31, 2020